Table 1. Health-Related Quality-of-Life Scores.
HRQOL score | ADT plus AAP | APA alone | AAP plus APA |
---|---|---|---|
Baseline HRQOL score, mean (SD) | |||
Physical well-being | 23.9 (5.1) | 23.4 (5.0) | 23.9 (4.0) |
Functional well-being | 19.6 (5.9) | 19.2 (6.1) | 18.8 (6.1) |
Social well-being | 21.4 (6.1) | 21.4 (6.0) | 20.6 (5.8) |
Emotional well-being | 19.7 (3.8) | 18.6 (4.9) | 19.2 (4.0) |
Prostate cancer subscale | 34.0 (8.7) | 33.7 (7.1) | 33.0 (6.1) |
FACT-G total score | 84.3 (17.2) | 82.6 (17.9) | 82.4 (13.7) |
FACT-P total score | 118.5 (24.3) | 116.1 (23.9) | 114.9 (18.1) |
Week 25 HRQOL score, mean (SD) | |||
Physical well-being | 24.5 (4.2) | 23.6 (4.9) | 23.2 (5.0) |
Functional well-being | 19.7 (5.7) | 19.5 (4.4) | 20.4 (5.1) |
Social well-being | 20.8 (5.2) | 20.9 (4.9) | 20.9 (4.0) |
Emotional well-being | 20.7 (4.3) | 19.9 (2.5) | 20.7 (3.5) |
Prostate cancer subscale | 36.2 (6.1) | 35.3 (5.8) | 34.4 (6.9) |
FACT-G total score | 86.1 (15.8) | 84.1 (12.4) | 85.4 (14.6) |
FACT-P total score | 122.3 (20.4) | 119.5 (16.4) | 119.9 (20.3) |
Abbreviations: AAP, abiraterone acetate plus prednisone; ADT, androgen deprivation therapy; APA, apalutamide; FACT-G, Functional Assessment of Cancer Therapy–General; FACT-P, Functional Assessment of Cancer Therapy–Prostate; HRQOL, health-related quality of life.